Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,210 across all filing types
Latest filing 2017-09-14 Regulatory Filings
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Succesfuldt fase III-studie for ALKs tabletvaccine mod træpollenallergi
Regulatory Filings Classification · 95% confidence The document is a corporate announcement (Selskabsmeddelelse) from ALK-Abelló regarding the successful completion of a Phase III clinical trial for a tree pollen allergy tablet vaccine. It details the study results, methodology, and future regulatory plans. As this is a specific corporate announcement regarding business/clinical developments that does not fit into financial reporting, dividend notices, or governance categories, it is classified as a general regulatory filing (RNS).
2017-09-14 English
Succesfuldt fase III-studie for ALKs tabletvaccine mod træpollenallergi
Regulatory Filings Classification · 72% confidence The document is a press release-style announcement of clinical Phase III study results by ALK, discussing product development and trial outcomes. It contains no financial statements, management change notifications, dividend or share capital announcements, nor is it an actual regulatory form (e.g., 10-K, interim report, proxy statement). It does not fit any specific category like earnings release, M&A, capital update, etc. Therefore, it falls under the fallback category for miscellaneous regulatory announcements.
2017-09-14 Danish
Director's Dealing 2017
Director's Dealing Classification · 100% confidence The document explicitly references 'Regulation (EU) No 596/2014 on market abuse (the Market Abuse Regulation)' and details transactions (delivery of shares) conducted by persons discharging managerial responsibilities (President & CEO and Board Members). This structure and content are characteristic of mandatory insider trading disclosures, specifically concerning transactions by directors/executives. This aligns directly with the definition for Director's Dealing (DIRS).
2017-09-04 Danish
Remuneration Information 2017
Remuneration Information Classification · 99% confidence The document explicitly references 'artikel 19 i EU forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen)' and proceeds to detail transactions made by persons discharging managerial responsibilities ('personer med ledelsesansvar') such as the CEO and board members. The content focuses on the 'Levering af aktier' (Delivery of shares) resulting from incentive plans, which constitutes insider trading or director's dealing disclosure required under MAR (Market Abuse Regulation). This directly matches the definition for Director's Dealing (DIRS).
2017-09-04 English
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
Director's Dealing Classification · 100% confidence The document is a formal notification of transactions by persons discharging managerial responsibilities (PDMRs) at ALK-Abelló A/S. It explicitly references Article 19 of the EU Market Abuse Regulation (MAR) and provides detailed tables of share deliveries to executives (Carsten Hellmann, Henrik Jacobi, etc.). This fits the definition of 'Director's Dealing' (DIRS), which covers insider trades and share transactions by company directors and executives.
2017-09-04 English
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by persons discharging managerial responsibilities (PDMRs) at ALK-Abelló A/S. It explicitly references Article 19 of the EU Market Abuse Regulation (MAR), which governs the reporting of insider/director dealings. The content details specific share deliveries to the CEO and other board members, including names, positions, transaction dates, and volumes. This aligns perfectly with the definition of 'Director's Dealing' (DIRS).
2017-09-04 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.